Related Experiment Videos

Effects of interferon-alpha on cellular proliferation and adhesion of breast carcinoma cells

M Maemura1, Y Iino, J Horiguchi

  • 1Second Department of Surgery, Gunma University School of Medicine, Maebashi, Gunma 371-8511, Japan.

Oncology Reports
|April 16, 1999
PubMed

Insights

Interferon-alpha (IFN-alpha) significantly inhibits breast cancer cell proliferation and adhesion. These findings suggest potential therapeutic applications for metastatic breast carcinoma treatment.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Metastatic breast carcinoma presents significant treatment challenges.
  • Interferon-alpha (IFN-alpha) is a cytokine with known immunomodulatory and antiproliferative properties.

Purpose of the Study:

  • To investigate the effects of IFN-alpha on MCF-7 breast carcinoma cell proliferation and adhesion.
  • To determine the impact of IFN-alpha on alpha2beta1 integrin expression in breast cancer cells.

Main Methods:

  • MCF-7 cells were treated with IFN-alpha (5x10^3 IU/ml).
  • Cell proliferation was assessed over 5 days.
  • Cell attachment assays were performed up to 48 hours.
  • Fluorescence activated cell sorter (FACS) analysis evaluated integrin expression.

Main Results:

  • IFN-alpha markedly inhibited MCF-7 cell proliferation.
  • Cellular adhesion mediated by alpha2beta1 integrin was reduced by IFN-alpha.
  • IFN-alpha treatment did not alter alpha2 and beta1 integrin cell surface expression at 24 hours.

Conclusions:

  • IFN-alpha exhibits potent anti-proliferative and anti-adhesive effects on breast carcinoma cells.
  • These properties indicate potential for IFN-alpha in managing metastatic breast carcinoma.

Related Concept Videos